- Poster presentation
- Open Access
Optimum management of asymptomatic moderate-severe degenerative mitral regurgitation: a role for T1 mapping in risk stratification?
© Edwards et al.; licensee BioMed Central Ltd. 2014
- Published: 16 January 2014
- Mitral Regurgitation
- Late Gadolinium Enhancement
- Myocardial Fibrosis
- Regurgitant Volume
- Left Ventricular Structure
The optimum timing of surgery in asymptomatic patients with severe degenerative mitral regurgitation (MR) is controversial and there are no randomised data to separate early repair from watchful waiting. Chronic volume overload may be a stimulus for progressive myocardial fibrosis, which could potentially be an additional marker for left ventricular (LV) recovery after surgery.
In total, 24 patients (mean age 62 +/- 16 years) with degenerative moderate or severe asymptomatic MR with no class 1 indication for surgery were recruited from a dedicated valve clinic in a University Hospital and compared with gender matched controls. All subjects underwent cardiac MRI (1.5T Siemens Avanto) for assessment of LV volumes, deformation (SPAMM tagging), late gadolinium enhancement (LE) and T1-mapping using a modified look-locker inversion recovery sequence (MOLLI) before and 15 minutes post gadolinium (0.1 mmol/Kg) for myocardial extracellular volume (ECV). Global ECV was the average measure from basal and mid short axis slices excluding LGE indicative of infarcted myocardium.
CMR parameters of structure and function
LV mass index (g/m2)
Peak longitudinal systolic strain (%)
Peak longitudinal systolic strain rate (s-1)
Peak basal circumferential strain (%)
Peak basal circumferential strain rate (s-1)
Peak mid circumferential strain (%)
Peak mid circumferential strain rate (s-1)
Patients with MR demonstrate a spectrum of myocardial fibrosis associated with reduced longitudinal and circumferential deformation and reduced peak VO2 max. These changes occur before changes in conventional markers of LV structure and function or an increase in BNP. The routine use of CMR may provide a rationale for improved risk stratification in patients with asymptomatic moderate-severe primary MR to optimise the risk/benefit of early surgery.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.